This trial is looking at how well a new drug called pumitamig works with chemotherapy for patients with triple-negative breast cancer (TNBC). The main goal is to see if this combination helps patients who cannot use another type of immunotherapy. Participants will be randomly assigned to receive either pumitamig with chemotherapy or a matching placebo with chemotherapy.
The trial ID is NCT07173751. It is a Phase 3 trial, meaning it is looking at how well the treatment works and how safe it is. This trial is FDA-regulated and aims to include 558 participants.
Who can join
This study is for adults aged 18 and older, both men and women, who have triple-negative breast cancer that cannot be treated with certain immunotherapies. Participants must have at least one measurable cancer lesion and provide a tissue sample. Those who have had specific prior treatments or are pregnant or breastfeeding cannot join. The trial team will confirm eligibility for each individual.
Condition
Breast Neoplasms
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be randomly placed into two groups. One group will receive pumitamig along with chemotherapy. The other group will receive a placebo that looks like the drug but has no active ingredients, also with chemotherapy. Everyone will receive chemotherapy as part of standard care.
Where
This trial is enrolling at 47 locations. Recruiting sites are listed first.
Bon Secours Cancer Institute at Memorial Regional
Mechanicsville, Virginia
Recruiting
Bon Secours Cancer Institute at St. Mary's
Richmond, Virginia
Recruiting
Bon Secours St. Francis Medical Center
Midlothian, Virginia
Recruiting
Cancer Care Specialists
Decatur, Illinois
Recruiting
Cancer Care Specialists of Illinois
O'Fallon, Illinois
Recruiting
Carle Foundation Hospital d/b/a Carle Cancer Center
Director of the Breast Cancer Center at NYU Langone’s Perlmutter Cancer Center. Treats breast cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Inaugural Jeffrey F. Moley Professor of Endocrine and Oncologic Surgery, WashU. Treats breast cancer. A surgeon is the doctor who removes cancer with an operation (adults). Recognized at state, national or international level.
Microsurgical breast reconstruction specialist, MSK. Treats breast cancer and mouth cancer. Offers microsurgical breast reconstruction, head and neck reconstruction and abdominal wall reconstruction.